The pandemic has certainly affected many aspects of life, but what about the medtech industry? Specifically for this audience, did COVID impact medtech investment strategy? As part of the recent Medtech MVP conference, host Geoff Pardo moderated a panel interview with four medtech investors to tackle that question and many more: Carter McNabb, Managing Director, River Cities Capital Funds; Darshana Zaveri, Managing Partner, Catalyst Health Ventures; Justin Klein, MD, JD, Co-Founder & Managing Partner, Vensana Capital; and Tara Butler, MD, Managing Director, Ascension Ventures. The panel also discussed aspects of the virtual world that are likely to remain in the entrepreneur/VC ecosystem, the latest drama around coverage and MCIT, the rise of consumerism and patient payment, the funding gap for early-stage companies, and the investment appetite for AI/data-driven diagnostics and devices. Listen now to catch these valuable insights! Panelists: Carter McNabb, Managing Director, River Cities Capital Funds Darshana Zaveri, Managing Partner, Catalyst Health Ventures Justin Klein, MD, JD, Co-Founder & Managing Partner, Vensana Capital Tara Butler, MD, Managing Director, Ascension Ventures